Futura Medical logo

FUM - Futura Medical Share Price

44.2p -1.6  -3.5%

Last Trade - 10:12am

Small Cap
Market Cap £131.5m
Enterprise Value £130.5m
Revenue £n/a
Position in Universe 979th / 1812
Unlock FUM Revenue
Relative Strength (%)
1m -4.36%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -45.5%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.029 0.17 0.36 0.000 0.032 0.000 -100.0%
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, FuturaMedical plc. revenues decreased from £32K to £0K. Net lossdecreased 73% to £2.4M. Revenues reflect a decrease indemand for the Company's products and services due tounfavorable market conditions. Lower net loss reflectsResearch and development costs decrease of 81% to £1.9M(expense), Administrative costs decrease of 13% to £1M(expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for FUM
Graphical History


FUM Revenue Unlock FUM Revenue

Net Income

FUM Net Income Unlock FUM Revenue

Normalised EPS

FUM Normalised EPS Unlock FUM Revenue

PE Ratio Range

FUM PE Ratio Range Unlock FUM Revenue

Dividend Yield Range

FUM Dividend Yield Range Unlock FUM Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
FUM EPS Forecasts Unlock FUM Revenue
Profile Summary

Futura Medical plc is a United Kingdom-based pharmaceutical company that develops products for consumer healthcare. The Company is engaged in the research and development of pharmaceutical drugs and medical devices and the commercial exploitation. It is also engaged in transdermal delivery and has developed a transdermal technology, DermaSys for the absorption of active molecules through the skin. It specializes in sexual health and pain relief, and has approximately five products in its development pipeline, which include CSD500, MED2002, TPR100, TIB200 and SPR300. Its CSD500 product incorporates an erectogenic gel (known as Zanifil gel) to help men maintain a firmer erection during intercourse whilst wearing a condom. Its MED2002 is a gel applied directly to the penis for the treatment of male erectile dysfunction (ED). The Company's TPR100 is a gel to provide pain relief. Its SPR300 is a gel, which combines methyl salicylate and menthol with the DermaSys delivery system.

Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated April 25, 2001
Public Since July 10, 2006
No. of Shareholders: n/a
No. of Employees: 13
Sector Healthcare
Industry Biotechnology & Medical Research
Index FTSE Aim All Share ,
Exchange London Stock Exchange (AIM)
Shares in Issue 287,070,971
Free Float (0.0%)
Eligible for
FUM Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for FUM
Upcoming Events for FUM
Thursday 24th June, 2021 Estimate
Futura Medical PLC Annual Shareholders Meeting
Tuesday 14th September, 2021 Estimate
Half Year 2021 Futura Medical PLC Earnings Release
Frequently Asked Questions for Futura Medical
What is the Futura Medical share price?

As of 10:12am, shares in Futura Medical are trading at 44.2p, giving the company a market capitalisation of £131.5m. This share price information is delayed by 15 minutes.

How has the Futura Medical share price performed this year?

Shares in Futura Medical are currently trading at 44.2p and the price has moved by 0.166k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Futura Medical price has moved by 0.125k% over the past year.

What are the analyst and broker recommendations for Futura Medical?

Of the analysts with advisory recommendations for Futura Medical, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Futura Medical is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Futura Medical next release its financial results?

Futura Medical is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Futura Medical dividend yield?

Futura Medical does not currently pay a dividend.

Does Futura Medical pay a dividend?

Futura Medical does not currently pay a dividend.

When does Futura Medical next pay dividends?

Futura Medical does not currently pay a dividend.

How do I buy Futura Medical shares?

To buy shares in Futura Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Futura Medical?

Shares in Futura Medical are currently trading at 44.2p, giving the company a market capitalisation of £131.5m.

Where are Futura Medical shares listed? Where are Futura Medical shares listed?

Here are the trading details for Futura Medical:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: FUM
What kind of share is Futura Medical?

Based on an overall assessment of its quality, value and momentum, Futura Medical is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Futura Medical share price forecast 2021?

Shares in Futura Medical are currently priced at 44.2p. At that level they are trading at 74.67% discount to the analyst consensus target price of 174.50.

Analysts covering Futura Medical currently have a consensus Earnings Per Share (EPS) forecast of -0.01116 for the next financial year.

How can I tell whether the Futura Medical share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Futura Medical. Over the past six months, the relative strength of its shares against the market has been 0.167k%. At the current price of 44.2p, shares in Futura Medical are trading at 78.21% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Futura Medical PE Ratio?

We were not able to find PE ratio data for Futura Medical.

Who are the key directors of Futura Medical?

Futura Medical's management team is headed by:

James Barder - CEO
Jonathan Freeman - NID
Lisa Arnold - NID
John Clarke - NEC
Ken James - EDR
Who are the major shareholders of Futura Medical?

Here are the top five shareholders of Futura Medical based on the size of their shareholding:

Lombard Odier Asset Management (Europe) Ltd Investment Advisor
Percentage owned: 21.08% (60.5m shares)
Adams (Terence) Individual Investor
Percentage owned: 6.91% (19.8m shares)
WT Lamb Investments Ltd Corporation
Percentage owned: 3.73% (10.7m shares)
Atlantis Investment Management Limited Investment Advisor/Hedge Fund
Percentage owned: 3.4% (9.77m shares)
Lamb (Robin Anthony) Individual Investor
Percentage owned: 3.28% (9.42m shares)
Similar to FUM
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.